cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

作者：Stephen T. Ferris, Vivek Durai, Renee Wu, Derek J. Theisen, Jeffrey P. Ward, Michael D. Bern, Jesse T. Davidson, Prachi Bagadia, Tiantian Liu, Carlos G. Briseño, Lijin Li, William E. Gillanders, Gregory F. Wu, Wayne M. Yokoyama, Theresa L. Murphy, Robert D. Schreiber, KENNETH M. M. MURPHY · 发表于：Nature · 年份：2020 · DOI：10.1038/s41586-020-2611-3 · 被引用次数：621 · 研究领域：Immunotherapy and Immune Responses、T-cell and B-cell Immunology、Immune Cell Function and Interaction